Mathematical modeling of extracorporeal CO2 removal therapy. A validation carried out on ten pigs by Habran, Simon et al.
Noname manuscript No.
(will be inserted by the editor)
Mathematical modeling of extracorporeal CO2 removal
therapy
A validation carried out on 10 pigs
Simon Habran · Thomas Desaive · Philippe Morimont · Bernard
Lambermont · Pierre Dauby
the date of receipt and acceptance should be inserted later
Abstract The Extracorporeal CO2 removal device
(ECCO2RD) is used in clinics to treat patients
suffering from respiratory failures like acute respiratory
distress syndrome (ARDS) or chronic obstructive
pulmonary disease (COPD). The aim of this device
is to decarboxylate blood externally with low blood
flow. A mathematical model is proposed to describe
protective ventilation, ARDS and an extracorporeal
CO2 removal therapy (ECCO2RT). The simulations are
compared with experimental data carried out on 10
pigs. The results show a good agreement between the
mathematical simulations and the experimental data,
which provides a nice validation of the model. This
model is thus able to predict the decrease of PCO2
during ECCO2RT for different blood flows across the
extracorporeal lung support.
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1 Introduction
Acute Respiratory Distress Syndrome (ARDS) is
still life threatening despite new strategies in
mechanical ventilations [28,18,8]. Mortality and
morbidity of chronic obstructive pulmonary disease
(COPD) are also considerable [34,7]. For moderate
ARDS (PaO2/FI,O2 > 100 mmHg [10], where
PaO2 is the arterial partial pressure in O2 and
FI,O2 is the inspired oxygen fraction) or COPD,
a small extracorporeal lung support (ECLS), called
the extracorporeal CO2 removal device (ECCO2RD),
can be used [23,4,9,33,1,32] (see Fig. 1). The aim
of such a device is to decrease the CO2 partial
pressure without being too invasive, while the effect on
oxygenation remains very low with this configuration.
The main difference between an ECCO2RD and a larger
ECLS used in veno-venous extracorporeal membrane
oxygenation (vv-ECMO) is the volume of the gas
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Fig. 1 Extracorporeal lung support (ECLS). RA is the right
atrium and IVC is the inferior vena cava. Figure adapted from
M.J. Murray and D.J. Cook [21].
exchanger, which is smaller for ECCO2RD. Given the
small volume of the gas exchanger in the ECCO2RD,
the blood flow entering the device must be smaller
than 0.8 l/min (see, as an exemple, the ECCO2RD of
NovaLung R© [37]).
The purpose of this paper is to develop and
validate a mathematical model of the respiratory
system assisted by an ECCO2RD to improve the use
of this device. More precisely, before starting the
extracorporeal CO2 removal therapy (ECCO2RT), it
is important to assess the appropriate blood flow
that must cross the device for a given patient’s
status and therapeutic strategy. Indeed, if this blood
flow has been determined, clinicians can decide if an
ECCO2RD can be used instead of a larger ECLS
and they can also choose the appropriate cannulae
size, which must be kept as small as possible in
order to reduce complications, like hemorrhage and
infections. Developing a mathematical tool to facilitate
this preliminary step of care is the main long-term
target of this research. In order to propose solutions
adapted to the patient’s status, the mathematical
model is made as patient-specific as possible given
the available data in the intensive care unit (ICU). In
addition, the model has to be simple enough to allow
real-time parameter identification, but also complex
enough to be able to simulate pulmonary abnormalities
and the respiratory system when protective ventilation
is introduced and when an ECCO2RD is switched on.
Scientists have already developed several mathe-
matical models of the respiratory system (lung gas ex-
change and tissues gas exchange) for many years [12,
35,3] but these models usually do not take into account
pulmonary gas exchange abnormalities like ARDS and
COPD. Some authors have proposed modeling these
abnormalities by including a perfusion/ventilation mis-
match [16] or by decreasing the diffusion across the
alveolar capillary membrane [29]. However, very few
authors have developed models of the respiratory sys-
tem connected to an extracorporeal lung support [6,36,
22,20]. The models of Walter et al. [36] and Brendel
et al. [6] describe lung, tissues and ECCO2RD gas ex-
change but to account for gas exchange abnormalities in
the lung, these authors introduce two purely empirical
parameters. The appropriate account of gas exchange
abnormalities is of paramount importance in this work
and parameters with a clear physiological interpretation
are introduced to describe these abnormalities. More-
over, the goal of the authors cited above is different
from ours since they use their models in a control algo-
rithm designed to maintain appropriate long-term gas
contents of the blood, while our approach will help clin-
icians determining the best settings of an ECCO2RD
before it is used.
In the following sections, the different components
of the mathematical model are described and the
experimental procedures that were carried out on
10 pigs are presented. Then the model predictions
are compared to the data. Finally, these results are
analyzed and discussed.
2 Methods
2.1 Mathematical modeling
The model is a lumped parameter model of the
respiratory system connected to an ECCO2RD. Besides
the ECCO2RD, 2 other compartments are considered:
one lung compartment and one tissues compartment
(the 3 compartments are sketched in Fig. 2). The
equations of the model will not be presented here
since the different components were already introduced
separately elsewhere. However, for the interested
reader, the mathematical model is recalled in Appendix
A.
The impairments of pulmonary gas exchange is
described by two parameters: fs which describes the
importance of the pulmonary shunt (this parameter is
also used in the works of D. S. Kabring et al. [16] and of
S. E. Rees et al. [29]) and V˙L which is the mean effective
ventilation (the ventilation that actually participates
in gas exchange). In addition, the production of CO2
(MRCO2) and the consumption of O2 (MRO2) by
metabolism are two important parameters for the
appropriate description of the respiratory system. The
Mathematical modeling of extracorporeal CO2 removal therapy 3	!
FI,O2
FI,CO2
c
V˙L
FL,CO2
FL,O2
Ca,CO2
Ca,O2
Cv,CO2
Cv,O2
V˙D
FD,CO2
FD,O2 FID,O2
FID,CO2
Qc · (1  fd)
Cvd,CO2
Cvd,O2
Cd,O2
Cd,CO2
fs · Qc
(1  fs) · Qc Cl,CO2Cl,O2
Lung 
Tissues 
ECCO2RD 
Fig. 2 Model of pulmonary gas exchange connected to an
ECCO2RD. FI,i, Ca,i and Cv,i are respectively the inspired
fraction, the concentration in arteries and the concentration
in veins of component i (i = O2 or CO2). Qc is the mean
cardiac blood flow. fs and fd are the fraction of pulmonary
blood crossing the shunt and the fraction of blood passing
through by the ECCO2RD. V˙D is the ventilation of the
ECCO2RD and V˙L is the mean effective ventilation of the
lungs. The other symbols are defined in Appendix A.
values of these four parameters are estimated for each
subject as explained in section 2.3.2.
An appropriate blood chemistry model is also
needed. In the present work, the relation between
O2 concentration and O2 partial pressure PO2 follows
the equations of Grodins et al. [12] and the relation
between total CO2 concentration CCO2 , pH in blood
plasma and CO2 partial pressure PCO2 follows the
equations of Trueb et al. [35]. Note however that in
the CCO2 -PCO2 relation, a correction term kHCO3 must
be introduced to account for variations in standard
HCO3 concentration between individuals (more details
are provided in section 2.3.1).
2.2 Experimental data
Two sets of retrospective experiments (approved by
the Ethics Committee of the Medical Faculty of the
University of Lie`ge) including an ECCO2RD are used
to validate the mathematical model. The first set of
experiments, that are referred to as experiments H in
the text below, are carried out on 4 healthy pigs, named
H1 to H4, subject to protective ventilation. For the 6
animals A1 to A6 of experiments A, ARDS is induced
in addition to protective ventilation (for the detailed
protocol of the induction of ARDS, see Morimont et
al. [24]). Pigs have been chosen for the animal trials
because their cardiovascular and respiratory physiology
are similar to human.
At the beginning of both sets of experiments,
the pigs are anesthetized and intubated. After a
30 min stabilization period, whose end defines the
baseline situation, several experimental data (blood
flow, CO2 and O2 concentrations in venous and arterial
blood samples) are measured and the settings of the
ventilator are also recorded. Then protective ventilation
is introduced for about 45 min. In experiments A,
ARDS is induced during this phase of the protocol by
the normal saline lavage method [24]. After that, the
ECCO2RD (PALP
R©, Maquet, Germany) is switched on
to remove the excess CO2. In all experiments, the gas
flow through the device is set to 10 liters of atmospheric
air per minute. The blood flow in the ECCO2RD is
fixed to several values, which are specified in the results
section.
The body blood flow is measured with thermod-
ilution technique (PiCCO R©, Pulsion, Germany) and
also with an admittance pressure-volume catheter
(Transonic R©, USA) in the right ventricle. Tidal vol-
ume, FI,O2 , respiratory frequency and driving pressure
are fixed by the ventilator (Engstro¨m Carestation R©,
General Electric, Germany) and note that FI,CO2 is
always equal to 0. Arterial and venous blood sam-
ples are analyzed during the experimentation with a
RapidPoint500 R© device (Siemens, Germany). In exper-
iments H, additional blood samples are analyzed at
the inlet and outlet cannulae and the gas exiting the
ECCO2RD is also analyzed with a CARBOCAP
R© de-
vice (Vaisala, Finland).
Note that the two sets of experiments are important
for the purpose of this work since they complement one
another. Experiments H are needed because more data
is available and the estimation of all the parameters of
the model is feasible. However, the model must also
be validated in case of gas exchange abnormalities.
Therefore, experiments A are also needed since an
ARDS is induced.
2.3 Estimation of the parameters
As already mentioned in section 2.1, several parameters
describe the patient’s status (in this case the
animal’s status) and must be estimated with several
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measurements. These parameters are thus subject-
specific and their estimation is of course crucial.
The parameters related to the blood chemistry are
considered in the first subsection below while those
related to the lungs and tissues compartments are
discussed in the second subsection. These parameters
are estimated for each pig and their values will be given
in section 4. Other parameters, which are not subject
specific, must also be considered in the mathematical
model and are described in the Appendix A.5. Some of
these parameters are taken from the literature and are
derived from human study. These parameter values are
also discussed in the Appendix A.5
In addition, the value of the diffusion coefficient
characterizing the membrane of the ECCO2RD is
not provided by the manufacturer and this quantity
must also be considered as a parameter. Its value is
determined by a procedure which is explained in the
last subsection below.
2.3.1 Blood chemistry
Quantity kHCO3 is a subject-specific parameter in the
equations of Trueb et al. [35] and it must be evaluated
for each pig. Its values is assumed constant in time
and can be estimated by using values of pH, PCO2 and
the haemoglobin saturation with O2 in arteries during
baseline situation.
2.3.2 Gas exchange in the lungs and in the tissues
MRCO2 and MRO2 describe the CO2 production and
O2 consumption by the tissue. These parameters are
assumed to not be affected by the ventilator settings
or by the induction of ARDS. These quantities are
thus estimated only at baseline for each animal. Using
the values of cardiac output and O2 concentrations
in arterial and venous blood samples in a time
independent situation, parameter MRO2 can be
determined. For the CO2 production in the tissues, the
equality MRCO2 = MRO2 is assumed. Note also that
the body temperature of the animals is not controlled
in our experiments and a significant decrease of the
temperature is observed as soon as the ECCO2RT is
started (blood loses heat in the pipes and in the device).
This temperature decrease induces a change in the
metabolism and the values of MRCO2 and MRO2 have
to be modified accordingly (see Appendix B for the
details). However, since the temperature of the body
is controlled in the ICU, it will not be necessary to take
this effect into account in a future application of the
mathematical model in clinics.
Parameters fs and V˙L describe the global efficiency
of gas exchange in the lungs and their estimation is very
important. To our knowledge, this present approach is
unique in the literature since it is the first time that the
pulmonary gas exchange abnormalities are described
with these two parameters when an ECLS is connected
to the respiratory system. The settings of the ventilator
(tidal volume and respiratory frequency) and ARDS
notably influence the gas exchange. The parameters
fs and V˙L must be thus re-evaluated each time these
settings are modified and after the induction of ARDS.
For this reason, these quantities must be identified twice
in both experiments: once during baseline situation
and once during protective ventilation (combined with
ARDS induction in experiments A). The identification
of these parameters is obtained by fitting the
measurements of arterial PCO2 and PO2 (the venous
counterparts being linked to the arterial values by
the previously determined MRCO2 and MRO2) with
the corresponding simulated values. During baseline,
the system is completely stabilized and the variables
are thus time independent. The identification of these
parameters is more delicate after introducing the
protective ventilation and inducing ARDS. Indeed this
phase of the experiment is usually too short (45 min)
to reach a steady state in the respiratory system. In
that situation, the fitting of fs and V˙L is based on the
comparison of the measurements and the time evolution
obtained from the solution of the differential equations.
2.3.3 Diffusion in the ECCO2RD
The CO2 exchanges in the ECCO2RD is characterized
by the CO2 diffusion coefficient across the synthetic
membrane DCO2 . Its value is independent of the
patient’s status and of the ventilator settings. It can
be obtained by fitting the predictions of the ECCO2RD
mathematical model with measures of PCO2 in the inlet
and outlet canulae and in the gas flowing out of the
device.
For the O2 diffusion coefficient across the synthetic
membrane DO2 , the measurements of the O2 fraction
in the gas flowing out of the ECCO2RD was not
available. In addition, the accuracy of measurements
in blood is not high enough to estimate DO2 in our
pig experiments. For these reasons, DO2 is assumed to
be 40 times smaller than DCO2 as is the case for the
heart-lung machine described in [22]. This estimation
of DO2 is a bit rough but it is still sufficient for the
main purpose of this work. Indeed this quantity has
only a minute influence on the time evolution of PCO2,
which is the main quantity of interest in this work.
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2.4 Statistics
The goal of the mathematical model is to predict the
decrease of PCO2 for different blood flows entering the
ECCO2RD. All parameters are thus estimated before
the ECCO2RT and the model must be able to describe
this therapy without changing any parameter. To test
the predictions of the model, the mean difference (|∆P |)
between the simulations and the experimental data is
estimated with the following formula:
|∆P | = 1
n
n∑
i=1
|Psimi − Pexpi| (1)
where n is the number of measurements, Pexpi is the
PCO2 measurement i and Psimi is the corresponding
PCO2 simulated with the model. The mean relative
difference (|∆P/P |) provides another way to estimate
the error :
|∆P/P | = 1
n
n∑
i=1
|Psimi − Pexpi|
Pexpi
. (2)
In addition, in order to estimate if the model
tends to overestimate or to underestimate the partial
pressure, the mean difference and the mean relative
difference are also computed without the absolute value
(and the corresponding symbols are written as ∆P and
∆P/P ).
3 Results
In this section, the mathematical model is tested by
simulating an ECCO2RT and the numerical results
of the model are compared to the experimental data
obtained in experiments H and experiments A. In the
first subsection, the values of the specific parameters
corresponding to each animal are given. Then, the
results of the simulations are presented.
3.1 Values of the parameters
To determine the diffusion coefficients across the
membrane of the ECCO2RD, we use the data of
experiments H. Using the method presented in section
2.3, one finds DCO2= 6.33 ×10−5 lCO2/s/mmHg
and DO2 = 1.58 × 10−6 lO2/s/mmHg. As already
mentioned, the settings of the ECCO2RD are such that
the atmospheric air flow is always equal to 10 liters per
minute, while parameter Qd is changed several times
(Qd = 200 ml/min, Qd = 400 ml/min and Qd = 600
ml/min) for experiments H and set to one value (around
700 ml/min) for experiments A.
The other parameters of the model are given in
Table 1 for all animals. Parameter FI,O2 is one of the
ventilator settings. On the other hand, the values of
MRCO2 , MRO2 , kHCO3 , fs and V˙L are determined
by the procedures described in section 2.3. Note that
in Table 1, parameter fs increases when protective
ventilation is induced and it increases even more when
protective ventilation is coupled with ARDS. On the
other hand, the effective ventilation V˙L decreases when
protective ventilation is induced.
Cardiac blood flow values for the different animals
during the experiments are also parameters of the
model and Fig. 3 provides these values for pigs H2 and
A6 for which detailed results are presented below.
The other parameters, which are not subject
specific, are given in Table 3 in Appendix A.5.
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Fig. 3 Time evolution of the cardiac blood flows for pigs H2
and A6.
3.2 Comparison between experimental and numerical
results
Using the values of the parameters given above,
the mathematical model is able to describe the gas
exchange for experiments H and experiments A during
the ECCO2RT. The main results consist of the time
evolution of PCO2 at several places in the body. Fig. 4
illustrates the time evolution of PCO2 in veins, in the
right ventricle and in arteries for pig H2 and Fig. 5
illustrates the time evolution of PCO2 in veins and
in arteries for pig A6. The results for the other pigs
are not presented since they present similar features.
Note that the error on the measurements is equal to
0.03 × {value of the measurement} + 0.17 mmHg,
according to the manufacturer of the RapidPoint500 R©
device. In the figures, the vertical lines indicate the
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Table 1 Measurements, settings of the ventilator and identified parameters for experiments H (H1 − H4) and A (A1 − A6)
Experiments H (“healthy” pigs) Experiments A (pigs with ARDS)
Data H1 H2 H3 H4 A1 A2 A3 A4 A5 A6
Baseline situation
Measurements
Weight (kg) 22 29 28 31 28 35 22 22.7 30 30
Ventilator settings
FI,O2 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 1 0.5
Identified parameters
MRCO2 (lCO2/min)
= MRO2 (lO2/min)
0.147 0.202 0.183 0.226 0.173 0.182 0.142 0.108 0.133 0.195
kHCO3 (lCO2/l) 0.06 0.028 0.068 -0.001 0.042 0.05 -0.053 0.018 0.055 0.06
fs 0.044 0.066 0.047 0.029 0.037 0.08 0.133 0.08 0.059 0.050
V˙L (l/min) 3 5.85 4.325 6.875 3.24 3.9 2.76 2.2 3.92 4.58
Protective ventilation Protective ventilation and ARDS
Ventilator settings
FI,O2 1 1 1 1 0.5 0.5 1 1 1 1
Identified parameters
fs 0.105 0.092 0.081 0.128 0.304 0.436 0.49 0.57 0.409 0.532
V˙L (l/min) 0.93 1.8 1.695 2.1 1.58 1.92 1.44 1.2 2 2.66
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Fig. 4 Time evolution of calculated (curves) and measured
(crosses, circles and diamonds) CO2 partial pressures in veins,
in the right ventricle and in arteries for pig H2. The labels
PV and QD 200 (QD 400 and QD 600) mean respectively
the start of protective ventilation and blood flow through the
ECCO2RD set to 200 (400 and 600) ml/min.
beginning of the different phases of the experiments.
As expected, the PCO2 in the body increases when
protective ventilation and ARDS are induced and
decreases when the ECCO2RD is initialized.
Figs. 4 and 5 show a good agreement between
the numerical simulations and the corresponding
experimental data. During baseline situation (the first
10 minutes in Fig 4 and Fig 5), the agreement is
perfect for the PCO2 in arteries since parameters fs
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Fig. 5 Time evolution of calculated (curves) and measured
(crosses and diamonds) CO2 partial pressures in veins and
in arteries for pig A6. The labels PV and QD 800 mean
respectively the start of protective ventilation and blood flow
through the ECCO2RD set to 800 ml/min.
and V˙L are identified to fit the PCO2 in arteries. On the
other hand, the agreement is not perfect for the PCO2
in veins because MRCO2 is not estimated with the
measurements but with the approximation MRCO2 =
MRO2 . After baseline situation, protective ventilation
is induced (combined with ARDS in experiments A)
and the agreement is still good since parameters
fs and V˙L are re-evaluated. Now the comparison
between experimental and numerical results during
ECCO2RT will be analysed in detail. During this
period, all parameters are kept constant and the
agreement between simulations and experimental data
remains quite good, for a relatively long period of
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time. Table 2 provides the mean errors ∆P and the
mean relative errors ∆P/P with and without absolute
value for each pig of the two sets of experiments.
The number of experimental data (# data) is also
given. Note that the standard deviation of the errors
is not given for experiments A since the number of
measurements is small (less than 5 measurements).
One can observe that the errors for experiments H are
larger than for experiments A. However, experiments H
have more experimental data in different parts of the
body (experiments A have only arteries measurements
during ECCO2RT). For experiments H, the model
always underestimates PCO2 (the value of ∆P and
∆P/P is always negative) whereas underestimations
and overestimations are almost as likely for experiments
A. In addition, the mean errors are also computed for all
pigs (last column) and one can observe that the global
relative error |∆P/P | is equal to 11%.
4 Discussion
This section discusses the physiological meaning of
important parameters and discusses the ability of
our model to predict the decrease of the PCO2
during ECCO2RT. The possible application of the
mathematical model in the ICU is also discussed and,
finally, the limitations of the model are described.
4.1 Modeling of lung gas exchange
Walter et al. [36] and Brendel et al. [6] have already
developed a 3 compartments mathematical model
(lung, tissues and ECCO2RD compartments) similar to
that used in our approach. However, the above authors
use two empirical parameters to describe pulmonary gas
exchange abnormalities. Since the aim of our work is to
find parameters specific to a given subject before the
ECCO2RT is initiated, the description of the possible
abnormalities is quite crucial. For this reason, our
model uses two parameters with clear physiological
meaning to describe the impairments of gas exchange:
fs which describes the importance of the pulmonary
shunt and V˙L which is the mean effective ventilation.
In the literature, the mean effective ventilation V˙L is
often not identified as in our approach, but directly
estimated [29,17]. V˙L depends on the tidal volume and
the respiratory frequency, which are easily known since
they are settings of the ventilator. But V˙L also depends
on the dead space VDead, which is much more difficult
to obtain. Some authors assume that this space is equal
to 150 ml for an adult patient [29], while others measure
the dead space with a stand-alone respiratory monitor
[17]. In our experiments on pigs, the assumption of a
human value equal to 150 ml can not be made. It is not
either possible to estimate VDead with a gas analyser at
the outlet of the ventilator. Indeed, the experimental
data related to the CO2 expired out of the ventilator
are not enough precise to estimate the dead space
with the small ventilation used in our experiments.
Consequently, V˙L is identified at the same time as
the pulmonary shunt fs and these two parameters
describe the efficiency of gas exchange in the lungs.
Whereas parameter fs describes the fraction of blood
that does not participate in gas exchange, parameter V˙L
describes the actual air flux in the lungs. In physiology,
the quality of gas exchange in the lungs depends on
many factors, such as for example, ventilation-perfusion
mismatch or the quality of diffusion across the alveolar-
capillary membrane. In the present work, these effects
are not explicitly modeled and parameters fs and V˙L
must thus be considered as lumped parameters that
allow global description in the mathematical model all
the possible anomalies of gas exchange.
During the animal experiments, the tidal volume
is decreased drastically when the protective ventilation
starts. Of course, the effective ventilation changes
with the tidal volume but the pulmonary shunt
can also change since the dynamics of the lung
is modified. The induction of ARDS has also an
impact on the pulmonary shunt. Therefore, it is
necessary that the two parameters are estimated twice:
first during the baseline situation and then during
protective ventilation (combined with ARDS induction
in experiments A). The changes of these two parameters
between the two phases are discussed in the next
subsection.
4.2 Values of the parameters
Table 1 shows that the two lumped parameters fs and
V˙L behave as physiologically expected. Indeed, during
ARDS, many alveoli do not work properly and the
increase of the pulmonary shunt with ARDS is observed
in physiology [2,31]. The value of fs during ARDS
(45.7±3.6%) is larger than in previous studies of human
ARDS (31±10% [16]) but note that the experiments are
carried out on pigs and that ARDS is not “real” since
it is only simulated by injecting water into the lungs.
The value of fs at baseline (6.3±0.9%) is also larger
than expected for a healthy human (2% [13]) but the
pigs are intubated and anesthetized and thus not in a
truly physiologically healthy state. The small increase
of fs during protective ventilation for experiments H
can be interpreted by the collapse of some alveoli when
the pressure in the lungs is lower. With regards to
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Table 2 Errors between the simulations and the measurements during the ECCO2RT for experiments H and A. The line #
data indicates the number of experimental measurements available during ECCO2RT.
Experiments H Experiments A
Data H1 H2 H3 H4 A1 A2 A3 A4 A5 A6 All pigs
|∆P | (mmHg) 13.15
± 8.00
10.03
± 6.60
6.88
± 5.48
7.97
± 5.66
5.96 6.03 0.07 5.57 0.79 3.88 6.03
± 7.72
|∆P/P | 0.19
± 0.11
0.15
± 0.06
0.12
± 0.05
0.12
± 0.05
0.12 0.14 0.002 0.14 0.02 0.12 0.11
± 0.002
∆P (mmHg) -13.13
± 10.68
-10.03
± 5.52
-4.71
± 6.29
-6.62
± 5.94
-5.96 6.03 -0.07 -5.57 -0.79 3.88 -3.7
± 17.83
∆P/P -0.19
± 0.11
-0.15 ±
0.06
-0.09
± 0.09
-0.11
± 0.08
-0.12 0.14 -0.002 -0.14 -0.02 0.12 -0.06
± 0.01
# data 23 23 24 16 4 2 1 2 1 3 10
parameter V˙L, its decrease during protective ventilation
is clearly related to the drastic decrease of the tidal
volume.
MRCO2 and MRO2 values are in the same range
as in previous studies. All pigs of experiment H and
pigs A1, A2 and A4 have MRO2 (and MRCO2) values
very close to the standard empirical relation used by
Karagiannidis et al. [15]: MRO2 (= MRCO2 ) = 7 ×
10−3lO2/min/kg.
4.3 Quality of the PCO2 prediction
Even if the CO2 removal therapies considered are
rather complex for experiments H, since the settings
of the device are changed several times during the
period of interest, the model is able to describe the
general behavior of the system throughout the whole
experiment. The global relative error |∆P/P | for all
pigs of experiments H and experiments A is larger
than the accuracy of the blood analyser RapidPoint500
(11% compared to 3%) but the simulation of the PCO2
prediction depends on several other measurements
like the cardiac output, the inspired fraction of O2
and the PO2. In addition, for the simulations, the
extracorporeal blood flow is assumed to be perfectly
controlled whereas in reality, it is difficult to achieve
that goal. Recall also that the parameters fs and
V˙L are kept constant throughout the ECCO2RT
and are estimated before ECCO2RT. Therefore, we
can consider that our mathematical model of the
respiratory system connected to an ECCO2RD can
predict rather nicely the decrease of the PCO2
during ECCO2RT. For this reason, our model can be
considered as validated by the pig experiments.
The purpose of the mathematical model is to
find an appropriate extracorporeal blood flow for a
specific patient. Therefore, it is interesting to know
how the 11% relative error on the PCO2 impacts the
prediction of the blood flow. To test the sensitivity
of the extracorporeal blood flow with respect to the
PCO2 error, we have considered the ”mean pig” of
all the experiments. This ”mean pig” is obtained by
considering the mean of all the parameters given in
Table 1 (MRCO2 = MRO2 = 0.17 l/min, V˙L = 1.7
l/min, fs = 0.25% and kHCO3 = 0.03 lCO2/l, FI,O2
= 0.9 and a weight of 28 kg) and we have used our
mathematical model to determine the blood flow that
allows to achieve a PCO2 equal to 50 mmHg in arteries
after 1 hour of ECCO2RT. Then, the blood flows
corresponding to 50+11% mmHg and 50-11% mmHg
is also determined. The situation is illustrated in Fig 6
and the values of the three blood flows are respectively
268 ml/min, 199 ml/min and 377 ml/min. The positive
and negative errors in PCO2 thus give rise to 26%
and 40% of imprecision in the calculated blood flows
respectively, which is not negligible but nevertheless
acceptable in comparison with the global error of all
our experiments. In addition, in a clinical environment,
the patients’ status is often quite unstable like our pig
experiments and it is reasonable to have an uncertainty
over the appropriated blood flow.
4.4 Application of the model in the ICU
The results show that the mathematical model is able
to predict the decrease of PCO2 during ECCO2RT
carried out on pigs. This is a very encouraging step
for trying to extend the use of this model to the ICU.
It could improve care for patients under ECCO2RT. In
the context of this possible extension of the use of the
model, two additional points need to be made.
First, recall that in the simulations described
in section 3.2, the cardiac blood flow, which is
continuously measured in experiments, is introduced as
a given function of time in the calculations. However,
if the model is to be used in the ICU before starting
the ECCO2RT in order to determine the best settings
of the device, the change of cardiac output is of
Mathematical modeling of extracorporeal CO2 removal therapy 9
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Fig. 6 Decrease of the PCO2 in arteries during ECCO2RT
for different extracorporeal blood flow.
course unknown when the calculations are carried out.
To check if this would affect the predictions of the
mathematical model, a constant cardiac blood flow is
introduced in our calculations and the corresponding
mean relative errors between the simulations and the
experimental data become 10.7%. This error is the
same than the previous one obtained with the time-
varying blood flow, which indicates that the predictions
are not affected if the blood flow is considered constant
. This is of course a very important result for the use
of the mathematical model in the ICU.
Second, it is interesting to mention that the time
needed for a numerical simulation of PCO2 decrease
during a one hour ECCO2RT is around 3 min (on a
standard laptop computer and using MATLAB R©). This
computation time is thus sufficiently small to allow the
model to participate in the rapid decision making that
is required by clinicians at the patients bedside in the
ICU.
4.5 Limitations
CO2 production MRCO2 and O2 consumption MRO2
are two important quantities in the functioning of
the respiratory system. These two quantities are equal
for carbohydrate metabolism but if the patient’s
metabolism uses different sources like fats or proteins,
MRCO2 is smaller than MRO2 [25,11]. Unfortunately,
because the total concentration of CO2 in the blood
depends on 3 chemical species (CO2 dissolved in blood,
HCO –3 and CO2 complexed with hemoglobin), the
identification of the value of MRCO2 from blood sample
analyses has proved to be quite delicate and even
impossible in our experiments. For this reason, we have
introduced the rough approximation of equal MRCO2
and MRO2 .
If the long-term purpose of this work is to provide
an additional therapeutic tool to clinicians, other
limitations must also be emphasized. First, the status of
the pigs used in experiments do not exactly correspond
to that of humans in the ICU. In the experiments,
hypercapnia was induced by protective ventilation and
injection of water in the lungs, but no real ARDS or
chronic obstructive pulmonary disease was considered.
In addition, even if the pig cardiopulmonary system
is close to that of human, ICU patients could have
different responses to ECCO2RT.
Finally, this mathematical model is validated only
for a specific ECLS, which is the Maquet ECCO2RD
(PALP R©, Germany). Other, and larger ECLS like vv-
ECMO, should also be considered. In particular, it is
worth mentioning that larger ECLS are also used to
oxygenate blood and this work do not consider this
possibility.
5 Conclusions and future works
In this work, a lumped parameter model of the
respiratory system connected to an extracorporeal CO2
removal device (ECCO2RD) is built. This device is
used to decrease the PCO2 when a patient suffers from
acute respiratory distress syndrome (ARDS) or from
chronic obstructive pulmonary disease (COPD). Two
parameters are introduced in the model to characterize
the possible impairments of gas exchange in the lung.
Parameter fs charaterises the pulmonary shunt and
is defined as the fraction of blood flow that does
not participate in gas exchange in the lungs. The
effective ventilation V˙L is the ventilation that actually
participates in gas exchange. The values of fs and V˙L
are identified from measurements available in the ICU
and are patient-specific. In the tissues, production of
CO2 and consumption of O2 by the metabolism are
considered as parameters of the model and are also
identified in a patient-specific way. Cardiac output is
another important parameter of the model. If all these
parameters are identified before the extracorporeal CO2
removal therapy (ECCO2RT), the mathematical model
can correctly simulate the decrease of PCO2 during
ECCO2RT.
To validate the mathematical model, PCO2
predictions are compared with experimental results
obtained in pigs. The results show that the model is able
to reproduce experimental data for quite long periods
of time (up to about 150 minutes for experiments H
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and up to about 60 minutes for experiments A) and
until a total decarboxylation of blood is reached. The
quite good agreement between the theoretical approach
and animal data can thus be considered as a strong
argument proving the validity of our model.
A next interesting step would be a detailed
validation of the model in an ICU environment,
using retrospective data corresponding to real human
pathologies. After this validation, the model could
become a useful tool for determining the most
appropriate blood flow that must be sent to the
ECCO2RD for a given therapeutic strategy and a final
PCO2-target. Then the most appropriate and smallest
canulae would be determined in order to obtain the
expected decarboxylation.
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Appendix
A Mathematical modeling
The 3 compartments of the mathematical model
are sketched in Fig. 2 (see section 2.1) and the
corresponding equations are described below.
Our model, which is sketched in Fig. 2 (see
section 2.1), is a lumped parameter model of the
respiratory system connected to an ECCO2RD. Besides
the ECCO2RD, two other compartments are considered
in our model: one lung compartment and one tissues
compartment (in which the metabolism of the patient
is taken into account). The lung compartment allows
the description of pulmonary abnormalities thanks to a
pulmonary shunt fs and an effective ventilation V˙L. In
addition, a blood chemistry model is also needed. All
the corresponding equations are described below and
the estimation of all the parameters are explained in
the last subsection.
A.1 Pulmonary gas exchange
Our model of pulmonary gas exchanges is based on the
work of Batzel et al. [3]. In their work, the authors
consider that diffusion of O2 and CO2 is fast so that
equilibrium can be assumed between the alveoli and the
pulmonary capillaries. The concentrations of O2 and
CO2 in the alveoli are thus equal to the concentrations
in the arteries. This assumption does not hold for gas
exchanges abnormalities and this model need to be
completed with additional parameters and additional
equations. Our model considers two physiological
parameters: fs which describes the importance of the
pulmonary shunt (like in the work of D. S. Kabring et
al. [16] and S. E. Rees et al. [29]) and V˙L which is the
mean effective ventilation. In this context, the material
balance of CO2 in the lungs can be written as :
VL,CO2 · P˙L,CO2 = 863 · (1− fs) ·Qc · (Cvd,CO2 − Cl,CO2)
+ V˙L · (PI,CO2 − PL,CO2) (3)
where:
– VL,CO2 (l) is the effective volume of CO2 in the
lungs,
– PL,CO2 = FL,CO2 · (Patm − 47) is the CO2
partial pressure in the air contained in the lungs
(in mmHg). FL,CO2 is the corresponding molar
fraction of CO2 in the lungs, Patm (mmHg) is the
atmospheric pressure and 47 mmHg is the saturated
water vapor pressure at 37◦C,
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– Qc (l/min) is the cardiac output,
– Cvd,CO2(lCO2/l) is the CO2 concentration in blood
entering the right atrium (mixture of venous blood
and treated blood from the ECCO2RD, see Fig. 2),
– Cl,CO2 (lCO2/l) is the CO2 concentration in the lung
(in the pulmonary capillaries),
– PI,CO2 = FI,CO2 · (Patm − 47) is the inspired CO2
partial pressure (in mmHg). FI,CO2 is the inspired
fraction of CO2 (always 0 in our approach),
– V˙L = fr · (VT − VDead) is the mean effective
ventilation of the lung (in l/min). fr (min−1) is the
respiratory frequency, VT (l) is the tidal volume and
VDead (l) is the dead space.
After decarboxylation of blood in the lungs, pulmonary
blood is mixed with venous blood from the shunt and
the concentration of CO2 in arteries Ca,CO2 (in lO2/l)
is given by:
Ca,CO2 = fs · Cvd,CO2 + (1− fs) · Cl,CO2 (4)
The pulmonary gas exchange equations for O2
are similar to equations 3 and 4 with corresponding
notation for the different quantities (VL,O2 , PL,O2 ,
FI,O2 , PI,O2 and FI,O2).
A.2 Tissues gas exchange
In the tissues, the material balance equations for O2
and CO2 are given by [3,36]:
VT,O2 · C˙v,O2 = Qc · (Ca,O2 − Cv,O2)−MRO2 (5a)
VT,CO2 · C˙v,CO2 = Qc · (Ca,CO2 − Cv,CO2) +MRCO2
(5b)
where VT,O2 and VT,CO2 are the effective volume of
CO2 and O2 in the tissues. Cv,O2 and Cv,CO2 are
the O2 and CO2 concentrations in veins (in lO2/l
and lCO2/l)). MRO2 and MRCO2 (in lO2/min and
lCO2/min)) are the quantities of O2 used and CO2
produced by metabolism.
A.3 ECCO2RD
ECCO2RD is considered as a second lung compartment
taking a fraction fd of the systemic blood flow Qc in
the inferior vena cava and rejecting the corresponding
decarboxylated blood in the right atrium (see Figs. 1
and 2). However, the diffusion of O2 and CO2 across the
synthetic membrane is less fast than across the lung
membrane and the exchange surface is smaller than
the alveolar-capillary membrane. As a consequence,
the hypothesis of equilibrium between the gas and
blood compartments in the device does not hold and
the diffusion of O2 and CO2 across the synthetic
membrane must be taken into account. A sketch of the
gas exchanger is shown in Fig. 7 [27]. The geometry
is quite complex (it is similar to a cross-flow plate
heat exchanger) and several assumptions have to be
considered to model this device. The geometry of the
device is reduced to one dimension and the gas and
blood flows are considered in opposite directions (see
for instance [6,19]. The material balance equations for
CO2 in the gas and in the blood are thus given by :
VD
∂FM,CO2
∂t
− V˙D
∂FM,CO2
∂X
= S ·Ds,CO2(Pm,CO2 − PM,CO2)
(6a)
Vd
∂Cm,CO2
∂t
+Qd
∂Cm,CO2
∂X
= S ·Ds,CO2(PM,CO2 − Pm,CO2)
(6b)
where,
– FM,CO2 and Cm,CO2(lCO2/l) are respectively the
CO2 fraction in the gas and the CO2 concentration
in the blood along the synthetic membrane,
– PM,CO2 and Pm,CO2 (mmHg) are the CO2 partial
pressures in the gas and in the blood along the
synthetic membrane,
– V˙D and Qd (l/s) are the gas and blood flows,
– VD and Vd (l) are respectively the volumes in the
gas side and in the blood side of the ECCO2RD,
– S (m2) is the exchange surface between the blood
side and the gas side,
– Ds,CO2 (lCO2/s/mmHg/m
2) is the CO2 diffusion
coefficient across the synthetic membrane and
– X = x/L is the nondimensional 1-D coordinate
where x is the distance along the ECCO2RD and
L is the length of the ECCO2RD.
The true exchange surface area of the device is given
by the manufacturer but is not directly related to the
exchange area of the 1-D model. Therefore, a global
equivalent diffusion coefficient DCO2 (lCO2/s/mmHg)
is considered instead of the product S×Ds,CO2 (as has
been done in previous studies [5,22]).
The first terms of the left hand sides of equations 6
describe the time accumulation of CO2 in the volumes
VD and Vd. The two boundary conditions for equations
6 give the values of the concentrations at the gas and
blood inlets. Since these two inlets correspond to
X=0 and X=1 respectively, the system of differential
equations and boundary conditions must be solved
iteratively (note that FM,i(0, t) = FD,i, Cm,i(0, t) =
Cv,i, FM,i(1, t) = FID,i and Cm,i(1, t) = Cd,i where i =
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O2 or CO2). The equations for the O2 material balance,
with the corresponding symbols (FM,O2 , Cm,O2 , DO2 ,
PM,O2 , Pm,O2 , PD,O2 and Pd,O2), are similar. Since the
time accumulation terms in the volumes VD and Vd are
small compared to the CO2 and O2 gas transfer, these
terms are considered as negligible in our simulations.
	
Cm,i(X)Cv,i Cd,i
FM,i(X) FID,iFD,i
Qd
X = 0 X = 1
V˙D
DO2
DCO2
Fig. 7 The Maquet R©’s gas exchanger on the left and the
model of the ECCO2RD on the right. All symbols are defined
in the text (i = O2 or CO2)
After crossing the device, the treated blood is
mixed with venous blood and the concentration of CO2
entering the right atrium Cvd,CO2 is given by:
Cvd,CO2 = fd · Cd,CO2 + (1− fd) · Cv,CO2 (7)
The concentration Cvd,O2 is calculated in the same way.
A.4 Blood chemistry
The relations between partial pressures and total
concentrations of gases are really complex in blood.
Indeed, O2 and CO2 are not only dissolved in
blood plasma since they can also be complexed with
hemoglobin. In addition, CO2 is also subject to the
hydratation/dehydratation reaction:
CO2 + H2O −−⇀↽− HCO −3 + H+ (8)
which influences the pH.
In the model, the relation between O2 concentration
CO2 and O2 partial pressure PO2 follows the equations
of Grodins et al. [12]:
CO2 = 4 · CHb · SatO2(PO2) + αO2 · PO2 (9a)
SatO2 =
(
1− exp(−S · PO2)
)2
(9b)
S = 0.44921 · pH − 0.10098 · pH2 + 0.0066815 · pH3 − 0.454
(9c)
where CHb (lHb/l) is the hemoglobin concentration,
SatO2 is the saturation of hemoglobin with O2, S is an
empiric parameter which accounts for the Bohr effect
and αO2 (lO2/l/mmHg) is the solubility coefficient of
O2 in blood plasma. The relations between total CO2
concentration CCO2 , pH in blood plasma and CO2
partial pressure PCO2 follow the equations of Trueb et
al. [35]:
CCO2 = (0.149− 0.014 · SatO2(PO2)) · PCO20.35 + kHCO3 ,
(10a)
CPl,CO2 = (1.19 + (4 · CHb − 0.2)) · CCO2 , (10b)
pH = − log10
(
KHCO3 ·
αCO2 · PCO2
CPl,CO2 − αCO2 · PCO2
)
,
(10c)
where kHCO3 (lCO2/l) is a correction term which
is introduced to compensate for variations between
individuals in standard HCO3 concentration [35],
CPl,CO2 (lCO2/l) is the total CO2 concentration in
blood plasma, KHCO3 is the equilibrium constant of
chemical equation 8 and αCO2 (lCO2/l/mmHg) is the
solubility coefficient of CO2 in blood plasma.
A.5 Parameters of the mathematical model
Many parameters appear in the mathematical model.
They are either estimated with experimental measure-
ments or taken from the literature. Table 3 provides a
list of all parameters and explain how their values are
determined.
For identified parameters, the identification proce-
dure is explained in the section 2.3. Other parame-
ters are directly estimated with a measuring device:
the cardiac blood flow is measured with thermodilution
technique (PiCCO R©, Pulsion, Germany) and also with
an admittance pressure-volume catheter (Transonic R©);
the haemoglobin concentration is measured with a
blood analyser (RapidPoint500 R©, Siemens, Germany).
Note that the cardiac output is a varying parameter
whose changes over time are measured continuously and
introduced in the model as an input function of time.
The haemoglobin concentration is estimated in arterial
and venous blood samples for every pig and the mean
of all these values is used.
The parameters taken from the literature are
derived from human study. αCO2 , αO2 and KHCO3
are taken from Rees et al. [30] and the effective
volumes VT,CO2 , VT,O2 , VL,CO2 and VT,O2 are assumed
proportional to the body weight and their values are
adapted from [3] (where these parameters are given for
a man weighing 75 kg). For the chemical parameters
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( αCO2 , αO2 and KHCO3), taking values from human
studies is reasonable since the human blood is very
similar to the pig blood. On the other hand, for the
effective volumes, the morphology of humans is quite
different than pigs and taking the values adapted from
Batzel et al. is a rough approximation. However, the
effective volumes influence just the unstable terms of
the system. Therefore, this approximation impacts only
the transitory terms which is not very important for the
goal of this paper.
Finally, some parameters are controlled during the
experiments since they are the settings of the ventilator
and of the ECCO2RD .
B Decrease of MRO2 and MRCO2 with
temperature
The detailed analysis of the temperature dependence
of metabolism is not the purpose of the present paper
since the final goal of our approach is to develop a model
to be used in the ICU, where temperature is controlled
and kept constant. However, in the experiments to
which the model was compared, the temperature of the
animals was decreasing. It was thus necessary to take
this effect into account to obtain a good validation of
the model, but given our final purpose, a rather rough
description of the temperature changes is of course
sufficient.
The decrease of temperature in the experiments
during ECCO2RT is illustrated in Fig. 8 for 3
pigs (for the other pigs, the temperature had not
been recorded). Unfortunately it was not possible to
estimate the corresponding decrease of parameters
MRO2 and MRCO2 . Indeed, the estimation of these
parameters requires stabilized (i.e. time independent)
data (see section 2.3), which were not available in the
experiments during the ECCO2RT.
To study the metabolism changes with temperature,
we made a retrospective analysis of other experiments
carried out in our lab (see [26]), for which appropriate
data were available. The composition of the gas expired
out the ventilator has been recorded continuously for
two pigs (pig 1 and pig 2). In a stabilized situation,
the CO2 production by the metabolism is equal to the
CO2 extraction by the ventilator and we can write the
following equation:
MRCO2 = V˙L · FE,CO2 , (11)
where FE,CO2 is the end tidal CO2 volume fraction
and V˙L is estimated from the tidal volume and the
respiratory frequency given by the ventilator and an
assumed dead space fixed equal to 30% of the tidal
volume [14]. The O2 consumption (MRO2) can be
estimated similarly. Fig. 9 and Fig. 10 show the time
evolutions ofMRCO2 andMRO2 and the time evolution
of temperature for the two pigs. We observe on these
figures that the temperature, MRO2 and MRCO2
decrease linearly. The decrease of MRO2 and MRCO2
are similar (a little bit larger for MRO2) . Therefore,
we use the slope of the linear interpolation of MRCO2 ,
MRO2 and that of the linear interpolation of the
temperature to estimate the decrease of the metabolism
production rates with temperature. For pigs 1 and 2,
the rates found are respectively 0.0138 l/min/◦C and
of 0.0125 l/min/◦C for MRCO2 and 0.0213 l/min/
◦C
and of 0.0275 l/min/◦C for MRO2 and we have taken
the mean value 0.0188 l/min/◦C. Then from Fig. 8,
we can calculate a mean time rate of change for the
temperature of the animals used in the experiments,
and we found the value 0.0255◦C/min. Finally, from
this value and from the value of the metabolism rate
of change with temperature, we deduce the following
estimation of the time rate of change of metabolism
production rates in the experiments: 4.78 × 10−4
l/min2. This value was used in our simulations for all
animals.
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Table 3 Parameters of the mathematical model
Parameters Descriptions Values
Identified parameters
DCO2 CO2 diffusion coefficient across the synthetic mem-
brane
6.33 ×10−5 lCO2/s/mmHg
DO2 O2 diffusion coefficient across the synthetic membrane 1.58 ×10−6 lO2/s/mmHg
fs Pulmonary shunt Subject-specific
kHCO3 Correction term for variations between individuals in
standard HCO3 concentration
Subject-specific
MRCO2 Quantities of CO2 produced by metabolism Subject-specific
MRO2 Quantities of O2 used by metabolism Subject-specific
V˙L Effective ventilation Subject-specific
Measured parameters
CHb Hemoglobin concentration 0.15 lHb/l
Qc Cardiac output Not constant
Parameters taken from the literature
αCO2 Solubility coefficient of CO2 in blood plasma 6.9 · 10−4lCO2/l/mmHg [30]
αO2 Solubility coefficient of O2 in blood plasma 2.837 · 10−5lO2/l/mmHg [30]
KHCO3 Equilibrium constant of chemical equation 8 10
−6.1 [30]
VL,CO2 Effective volume of CO2 in the lungs 43 ml/kg [3]
VL,O2 Effective volume of O2 in the lungs 33 ml/kg [3]
VT,CO2 Effective volume of CO2 in the tissues 200 ml/kg [3]
VT,O2 Effective volume of O2 in the tissues 80 ml/kg [3]
Ventilator settings
FI,CO2 Inspired fraction of CO2 0
FI,O2 inspired fraction of O2 Not constant
ECCO2RD settings
FID,CO2 Fraction of CO2 at the gas inlet for the ECCO2RD 0
FID,O2 Fraction of CO2 at the gas inlet for the ECCO2RD 0.21
Qd Extracorporeal blood flow Not constant
V˙D Ventilation of the ECCO2RD 10 l/min
